SEC-sourced researchBeta
BIIB
BIOGEN INC.
Company comparison ↗
Data passport
- CIK
- 0000875045
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Oct 5, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 9,835,600,000.0000 | Feb 6, 2026 |
| December 2024 | 9,675,900,000.0000 | Feb 6, 2026 |
| December 2025 | 9,890,600,000.0000 | Feb 6, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 9,890,600,000.0000 | 1,292,900,000.0000 | 2,204,600,000.0000 | 29,439,500,000.0000 | 11,182,700,000.0000 | Feb 6, 2026 |
| December 2024 | 9,675,900,000.0000 | 1,632,200,000.0000 | 2,875,500,000.0000 | 28,049,300,000.0000 | 11,333,300,000.0000 | Feb 6, 2026 |
| December 2023 | 9,835,600,000.0000 | 1,161,100,000.0000 | 1,547,200,000.0000 | — | — | Feb 6, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $9.89B | December 2025 | Feb 6, 2026 | 10-K |
| Previous period revenueRevenues | $9.68B | December 2024 | Feb 6, 2026 | 10-K |
| Net incomeNetIncomeLoss | $1.29B | December 2025 | Feb 6, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $2.2B | December 2025 | Feb 6, 2026 | 10-K |
| Total assetsAssets | $29.44B | December 2025 | Feb 6, 2026 | 10-K |
| Total liabilitiesLiabilities | $11.18B | December 2025 | Feb 6, 2026 | 10-K |